Skip to main content
Clinical Trials/TCTR20220519005
TCTR20220519005
Completed
Not Applicable

The level of synovial biomarkers following platelet-rich plasma injection for knee osteoarthritis related to radiographic severity

The Biologics for Knee Osteoarthritis Research Unit and The Thailand Science Research and Innovation Fund Chulalongkorn University0 sites126 target enrollmentMay 19, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
The Biologics for Knee Osteoarthritis Research Unit and The Thailand Science Research and Innovation Fund Chulalongkorn University
Enrollment
126
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 19, 2022
End Date
February 23, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
The Biologics for Knee Osteoarthritis Research Unit and The Thailand Science Research and Innovation Fund Chulalongkorn University

Eligibility Criteria

Inclusion Criteria

  • Selection criteria included knee OA according to the American College of Rheumatology (ACR), 45\-85 years of age, grade 1 to 4 of radiographic knee OA according to the Kellgren\-Lawrence system, body mass index (BMI) \< 30, \> 90\-degree arc of motion, \< 10\-degree anatomical knee deformity in the coronal plane, and no skin lesion around the affected knee.

Exclusion Criteria

  • Exclusion criteria included inflammatory arthritis, previous knee surgery, knee pain with an antalgic gait, and thrombocytopenia. In addition, all recruited patients had a 2\-week washing\-out period for any pain killers or non\-steroidal anti\-inflammatory drugs (NSAIDs) and joint supplements.

Outcomes

Primary Outcomes

Not specified

Similar Trials